TAVR

Transcatheter aortic valve replacement (TAVR) is a key structural heart procedure that has rapidly expanded in the decade since it was first FDA cleared. TAVR has come a paradigm shift in how many aortic stenosis patients are treated, now making up more than 50% of U.S. aortic valve replacements. It is less invasive than open heart surgery and recovery times are greatly reduced. TAVR can also be used in patients who otherwise are too high risk to undergo surgery. TAVR is referred to as transcatheter aortic valve implantation (TAVI) in many placed outside of the U.S. TAVR inspired the growing areas of transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

SGLT2 inhibitors after TAVR may boost survival, limit bioprosthetic valve dysfunction
Prescribing these drugs to TAVR patients could improve certain clinical outcomes, according to a new study of nearly 27,000 adults.
Performing PCI and TAVR together may improve in-hospital outcomes, long-term survival
When patients require PCI and TAVR, performing them at the same time is associated with both short- and long-term benefits.
Long-term data highlight Ross procedure's safety, effectiveness in younger patients
TAVR may get more attention, but the Ross procedure has also gained significant momentum in recent years. Ismail El-Hamamsy, MD, PhD, detailed his own team's success with the complex procedure.
DAPT during valve-in-valve TAVR may reduce stroke risk—more data still required
New research suggests there may be a cardiovascular benefit to considering dual antiplatelet therapy for valve-in-valve TAVR patients.
Cardiologists, heart surgeons sound alarm over widespread use of TAVR in low-risk patients
Are too many low-risk patients with severe AS undergoing TAVR instead of SAVR? According to one group of clinicians, "a significant public health concern may be looming."

Real-world data favor SAVR over TAVR when younger patients need aortic valve replacement

Researchers in Italy tracked data from more than 7,000 patients who underwent AVR between the ages of 65 and 80. TAVR was associated with a significantly higher long-term risk of mortality.

Newsweek ranked the 50 best heart hospitals in the world

Heart patients benefit when cardiologists follow a standardized TAVR protocol

Using a standardized approach, including the cusp overlap technique, is associated with improved patient outcomes when implanting Medtronic's self-expanding TAVR valves. Researchers tracked data from more than 600 patients treated all over the world, presenting their findings in JSCAI.

How anticoagulants may impact a patient’s risk of gastrointestinal bleeding after TAVR

Researchers tracked the rates of major gastrointestinal bleeding in patients with AFib randomized to receive edoxaban or a vitamin K antagonist after a successful TAVR procedure.

Boston Scientific pulls plug on TAVR devices after failing to gain FDA approval

After years of trying to catch up with the competition, Boston Scientific is moving on. The company is no longer seeking approval from the FDA or any other regulatory agencies for these devices, and all global sales have been discontinued.

Meril TAVR valves linked to 1-year outcomes similar to industry-leading devices from Medtronic, Edwards

Indian medtech company Meril Life Sciences has been manufacturing its Myval TAVR valves for years, but FDA approval has remained out of reach. These latest data represent a one-year update of the multicenter LANDMARK clinical trial.

Early TAVR or SAVR in asymptomatic patients linked to improved survival, reduced costs

Researchers explored data from more than 24,000 AVR patients, presenting their findings at EuroPCR in Paris.

Medtronic gains a key approval for Evolut TAVR valves

More patients can now undergo redo TAVR with a Medtronic valve than ever before.

Same-day discharge after TAVR linked to positive outcomes

When low-risk patients undergo transfemoral TAVR, they may be able to go home without spending a single night at the hospital.

TAVR

SGLT2 inhibitors after TAVR may boost survival, limit bioprosthetic valve dysfunction

Performing PCI and TAVR together may improve in-hospital outcomes, long-term survival

Long-term data highlight Ross procedure's safety, effectiveness in younger patients

DAPT during valve-in-valve TAVR may reduce stroke risk—more data still required

Cardiologists, heart surgeons sound alarm over widespread use of TAVR in low-risk patients